7 (a) D. R. Williams, P. D. Lowder, Y. G. Gu and D. A. Brooks, Tetra-
hedron Lett., 1997, 38, 331; (b) G. L. Mislin, A. Burger and M.
A. Abdallah, Tetrahedron, 2004, 60, 12139; (c) R. S. Brown, J. Dowden,
C. Mpreau and B. V. L. Potter, Tetrahedron Lett., 2002, 43, 6561.
8 (a) K. S. Ramasamy, R. Bandaru and D. J. Averett, J. Org. Chem., 2000,
65, 5849; (b) Y. Yu, H. Chen, L. Wang, X. Chen and B. Fu, Molecules,
2009, 14, 4858; (c) X. Fernandez and E. Dunach, Tetrahedron: Asymme-
try, 2001, 12, 1279; (d) X. Fernandez, R. Fellous, L. Lizzani Cuvelier,
M. Loiseau and E. Dunach, Tetrahedron Lett., 2001, 42, 1519; (e) S.
L. You and J. W. Kelly, Tetrahedron, 2005, 61, 241; (f) S. L. You and J.
W. Kelly, Chem.–Eur. J., 2004, 10, 71; (g) M. C. Bagley, J. W. Dale,
X. Xiong and J. Bower, Org. Lett., 2003, 5, 4421.
Oxidation of 2 with K2CO3
Reaction of thiazoline 2 with K2CO3 (1 equiv.) and catalyst 1 in
DMF (2 mL) produced thiazole 2a in 30% yield as well as a
mixture of angular hydroxide 15 and an unknown intermediate,
which is purportedly an angular peroxide, in a ratio of ca. 1 : 1.3
ratio, 22% and ca. 26% isolated yields respectively.
Acknowledgements
9 (a) Y. Huang, H. Gan, S. Li, J. Xu, X. Wu and H. Yao, Tetrahedron Lett.,
2010, 51, 1751; (b) Y. Huang, L. Ni, H. Gan, Y. He, J. Xu, X. Wu and
H. Yao, Tetrahedron, 2011, 67, 2066.
10 Quote from Aurora Fine Chemicals, San Diego, CA.
11 H. A. Zhong, J. A. Labinger and J. E. Bercaw, J. Am. Chem. Soc., 2002,
124, 1378–1399.
This work is sponsored by the University of Southern California,
Loker Hydrocarbon Research Institute, the Hydrocarbon
Research Foundation, and the American Cancer Society (grant
IRG-58-007-48) provided through USC Norris Cancer Center.
We are grateful to Dr Kortney Klinkel, Jonathan Chen, Erica
Good, and Jordan Lee for efforts in initiating this project, Dr
Brian Conley for insightful discussions, and Dr Timothy Stewart
and Dr Ralf Haiges for X-ray crystallography.
12 CCDC (a) 761477 and (b) 761476 contain the supplementary crystallo-
graphic data for these complexes.
13 Other examples of cis (N–N)CuII(OH2)3 include (a) Z. Xu, L.
K. Thompson and D. O. Miller, Inorg. Chem., 1997, 36, 3985;
(b) E. Burkholder, S. Wright, V. Golub, C. J. O’Connor and J. Zubieta,
Inorg. Chem., 2003, 42, 7460.
14 An additional portion of ca. 48% of azole-containing products were col-
lected. See ESI† for detail.
15 Conditions optimization available in ESI.†.
References
16 W. Adam and V. Ehrig, Synthesis, 1976, 817.
1 (a) K. Kanoh, Y. Matsuo, K. Adachi, H. Imagawa, M. Nishizawa and
Y. Shizuri, J. Antibiot., 2005, 58, 289; (b) G. Höfle, N. Bedorf,
H. Steinmetz, D. Schomburg, K. Gerth and H. Reichenbach, Angew.
Chem., 1996, 108, 1671; (c) P. C. Srivastava, M. V. Pickering, L.
B. Allen, D. G. Streeter, M. T. Campbell, J. T. Witkowski, R. W. Sidwell
and R. K. Robins, J. Med. Chem., 1977, 20, 256; (d) R. K. Robins, P.
C. Srivastava, V. L. Narayanan, J. Plowman and K. D. Paull, J. Med.
Chem., 1982, 25, 107; (e) Y. Lu, C. Li, Z. Wang, C. R. Ross 2nd,
J. Chen, J. T. Dalton, W. Li and D. D. Miller, J. Med. Chem., 2009, 52,
1701.
2 (a) M. de Souza, J. Sulfur Chem., 2005, 26, 429; (b) K. Gerth,
H. Irschik, H. Reichenbach and W. Trowitzsch, J. Antibiot., 1980, 33,
1474. For reviews of thiopeptide antibiotics, see (c) R. A. Hughes and C.
J. Moody, Angew. Chem., Int. Ed., 2007, 46, 7930; (d) M. C. Bagley, J.
W. Dale, E. A. Merrittm and X. Xiong, Chem. Rev., 2005, 105, 685.
3 Regarding copper-catalyzed aerobic oxidation of alcohols, seeI.
E. Markó, P. R. Giles, M. Tsukazaki, S. M. Brown and C. J. Urch,
Science, 1996, 274, 2044–2046.
4 N. A. Fuller and J. Walker, J. Chem. Soc. C., 1968, 12, 1526.
5 (a) D. L. Evans, D. K. Minster, U. Jordis, S. M. Hecht, A. L. Mazzu Jr
and A. I. Meyers, J. Org. Chem., 1979, 44, 497; (b) D. W. Knight,
G. Pattenden and D. E. Rippom, Synlett, 1990, 36; (c) P. Wipf and C.
P. Miller, J. Org. Chem., 1993, 58, 3604.
6 (a) F. Tavares and A. I. Meyers, Tetrahedron Lett., 1994, 35, 6803; (b) A.
I. Meyers and F. Tavares, Tetrahedron Lett., 1994, 35, 2481;
(c) F. Tavares and A. I. Meyers, J. Org. Chem., 1996, 61, 8207.
17 With addition of radical inhibitor vitamin E, the copper catalyzed
reaction solution remains a clear deep green color, which contrasts inhibi-
tor-free copper catalyzed condition solutions that are a clear deep brown
color.
18 Oxidation reactions were performed with copper-catalyzed or stoichio-
metric base-promoted conditions with the addition of 1 equiv. of H2O
and were monitored by 1H NMR spectroscopy. Results were compared to
1H NMR spectra from entries 1a and 1b of Table 3.
19 Purchased from Mallinckrodt and was used as received.
20 P. Raman, H. Razavi and J. W. Kelly, Org. Lett., 2000, 2, 3289–3292.
21 Purchased from Alfa Aesar and used as received.
22 V. Gududuru, E. Hurh, J. T. Dalton and D. D. Miller, J. Med. Chem.,
2005, 48, 2584–2588.
23 R. Shapiro, J. Org. Chem., 1993, 58, 5759–5764.
24 (a) S. Castellano, D. Kuck, M. Sala, E. Novellino, F. Lyko and
G. Sbardella, J. Med. Chem., 2008, 51, 2321–2325; (b) A. J. Phillips,
Y. Uto, P. Wipf, M. J. Reno and D. R. Williams, Org. Lett., 2000, 2,
1165–1168.
25 S. Tsuyoshi, T. Hiroshi, H. Kagoshima, Y. Yamamoto, T. Hosokawa,
K. Toshiyuhi, M. Nobuhisa, U. Takuya, A. Issei, K. Junichi, F. Tetsunori,
Y. Aki and N. Tetsuji, PCT Int. Appl., 2009.
26 H. Emtenas, L. Alderin and F. Almqvist, J. Org. Chem., 2001, 66, 6756–
6761.
27 D. L. Evans, D. K. Minster, U. Jordis, S. M. Hecht, A. L. Mazzu Jr. and
A. I. Meyers, J. Org. Chem., 1979, 44, 497–501.
8002 | Dalton Trans., 2012, 41, 7994–8002
This journal is © The Royal Society of Chemistry 2012